Moderna’s Lofty Aims To Prevent Diseases With Pandemic Potential
Plans Vaccines For 15 'Priority Pathogens'
The biotech has 15 pathogens in its sights and is also launching mRNA Access that will grant researchers the opportunity to use Moderna's technology platform to develop vaccines for emerging or neglected infectious diseases.
